Enable Medicine

Enable Medicine offers the Enable Cloud Platform, which provides a collaborative ecosystem and tools for generating, visualizing, and analyzing various biological image formats. The platform aims to organize and centralize high-parameter biological datasets to build searchable maps of human disease. Enable Medicine’s BIOS combines no-code applications and data science environments to facilitate end-to-end spatial biology workflows on the cloud, while Atlas centralizes and indexes biological data in a private and secure database. The platform supports the analysis of imaging data types, including CODEX, FUSION, IMC, and LOW-PLEX, and allows for the upload and analysis of image data across both high and low-plex assay types. Additionally, Enable Medicine offers a cloud-automated wet lab for generating high-parameter image data and collaborates with scientists to perform breakthrough research in fields such as oncology, atherosclerosis, and autoimmune diseases. Their services include end-to-end deep immunophenotyping, generating multi-modal data, and analyzing datasets with single-cell precision. The spatial biology lab evaluates 51+ protein and RNA biomarkers on human and murine tissues, while the analysis lab segments and phenotypes each cell in the tissue based on assessed biomarkers. The platform integrates multi-modal datasets to uncover spatial relationships and evaluate mechanisms of action, supporting proteomic assays like PhenoCycler (CODEX) and PhenoImager (Polaris) from Akoya Biosciences, and transcriptomic assays like Visium from 10x Genomics and GeoMx from Nanostring. Enable Medicine has partnerships with companies like Canopy Biosciences and Akoya Biosciences to enhance spatial analysis capabilities. The platform has generated and indexed over a petabyte of data, with 100+ active collaborators across academia and biopharma. Enable Medicine has imaged and analyzed over 20,000 samples, studying over 20 diseases across 75+ scientific studies, and has imaged over 200 unique proteins and deeply phenotyped over 500 million single cells. The company’s headquarters are located in Menlo Park, CA, with satellite offices in San Francisco, CA, and Boston, MA, and plans to open an office in New York, NY.